Alzheimers & Dementia-Translational Research & Clinical Interventions

metrics 2024

Driving Change through Open Access and Collaboration

Introduction

Alzheimer's & Dementia: Translational Research & Clinical Interventions, published by WILEY, is a premier open-access journal that has been at the forefront of innovations in the field of neurology and psychiatry since its inception in 2015. With an impressive impact factor reflecting its high-quality research contributions, this journal has been designated as Q1 in both Neurology (Clinical) and Psychiatry and Mental Health categories for 2023, ranking in the top percentiles of their respective Scopus fields. The journal aims to bridge the gap between research and clinical practice, promoting the translation of scientific discoveries into real-world applications for Alzheimer's disease and other dementias. Positioned in the United States, it is a valuable resource for researchers, clinicians, and students dedicated to advancing knowledge and treatment approaches in these critical areas. With its commitment to open access, the journal ensures that vital research is accessible to a broad audience, fostering collaboration and knowledge sharing across the global scientific community.

Metrics 2024

SCIMAGO Journal Rank-
Journal Impact Factor4.90
Journal Impact Factor (5 years)-
H-Index-
Journal IF Without Self4.90
Eigen Factor0.01
Normal Eigen Factor1.66
Influence-
Immediacy Index2.00
Cited Half Life3.60
Citing Half Life6.10
JCI1.32
Total Documents-
WOS Total Citations3056
SCIMAGO Total Citations-
SCIMAGO SELF Citations-
Scopus Journal Rank-
Cites / Document (2 Years)-
Cites / Document (3 Years)-
Cites / Document (4 Years)-

Metrics History

Rank 2024

IF (Web Of Science)

CLINICAL NEUROLOGY
Rank 35/277
Percentile 87.50
Quartile Q1
NEUROSCIENCES
Rank 54/310
Percentile 82.70
Quartile Q1

JCI (Web Of Science)

CLINICAL NEUROLOGY
Rank 39/278
Percentile 85.97
Quartile Q1
NEUROSCIENCES
Rank 51/310
Percentile 83.55
Quartile Q1

Quartile History

Similar Journals

Journal of Alzheimers Disease Reports

Transforming Understanding of Dementia
Publisher: IOS PRESSISSN: Frequency: 1 issue/year

Journal of Alzheimer's Disease Reports, published by IOS PRESS, is an essential open-access platform dedicated to advancing research in the fields of clinical psychology, geriatrics, gerontology, neuroscience, and psychiatry. Since its inception in 2017, this journal has rapidly gained recognition, achieving a commendable status reflected in its 2023 category quartiles, notably ranking Q2 in Clinical Psychology and Psychiatry and Mental Health. With a sustained commitment to disseminating high-quality research and facilitating collaboration among scientists, the journal offers insights into the critical aspects of Alzheimer's disease and related cognitive disorders. Given its positions in the Scopus ranks, it serves as a crucial resource for academics and practitioners alike, empowering them to contribute effectively to the ongoing discourse in cognitive health. The journal embraces open access, ensuring that all research findings are freely available to the global community, thereby enhancing visibility and engagement. With a focus on fostering innovation and knowledge transfer, Journal of Alzheimer's Disease Reports is poised to make an enduring impact in the field of dementia research.

Clinical Medicine Insights-Endocrinology and Diabetes

Empowering healthcare through open-access insights.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5514Frequency: 1 issue/year

Clinical Medicine Insights-Endocrinology and Diabetes, published by SAGE Publications Ltd, is a dynamic open-access journal dedicated to advancing the field of endocrinology and diabetes through high-quality research. Since its inception in 2008, this journal has become an essential resource for researchers, healthcare professionals, and students interested in the latest innovations and clinical practices in the realm of diabetes management and endocrine disorders. With an impressive 2023 JCR Q2 ranking in both Endocrinology, Diabetes and Metabolism and Internal Medicine, the journal serves as a pivotal platform for scholarly discussions, focusing on the convergence of clinical insights and therapeutic advancements. By offering an open-access model, the journal ensures that its articles are accessible to a global audience, thus promoting the dissemination of knowledge and best practices in the treatment of these critical health issues. The journal's commitment to excellence is reflected in its Scopus rankings, which position it among the noteworthy publications in the field. As it converges from 2009 to 2024, Clinical Medicine Insights-Endocrinology and Diabetes remains a cornerstone for impactful research, inspiring collaborations and serving as a vital reference for ongoing developments in patient care and treatment methodologies.

Current Geriatrics Reports

Transforming challenges into solutions in gerontology.
Publisher: SPRINGERISSN: Frequency: 4 issues/year

Current Geriatrics Reports is a pivotal journal published by SPRINGER, dedicated to disseminating cutting-edge research and insights in the dynamic field of geriatrics and gerontology. Launched in 2014 and ongoing until 2024, this journal plays a critical role in addressing the complex needs and challenges faced by the aging population. Although it currently holds a Q4 quartile ranking in its category and occupies the 84th position out of 116 in the Scopus metrics for Medicine, Geriatrics, and Gerontology, it serves as a vital platform for emerging research that shapes clinical practices and policy-making. Researchers, professionals, and students alike will find Current Geriatrics Reports to be an invaluable resource for staying updated on advancements, best practices, and innovations in geriatric care. While the journal is not open access, it continues to impact the field significantly and enrich contemporary discussions surrounding aging.

JAMA Neurology

Advancing Neurological Insights for Tomorrow's Treatments
Publisher: AMER MEDICAL ASSOCISSN: 2168-6149Frequency: 12 issues/year

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Translational Pediatrics

Elevating Pediatric Care Through Translational Science.
Publisher: AME PUBLISHING COMPANYISSN: 2224-4336Frequency: 12 issues/year

Translational Pediatrics is a leading journal in the field of Pediatrics, specializing in bridging the gap between laboratory research and clinical practice. Published by AME Publishing Company in Hong Kong, this journal aims to promote the translation of scientific discoveries into innovative interventions for child health. With its ISSN 2224-4336 and E-ISSN 2224-4344, the journal is accessible to a global audience, enhancing knowledge sharing among researchers, clinicians, and educators. Recognized in 2023 as a Q2 category journal in Pediatrics, Perinatology, and Child Health, it ranks 72nd out of 330 according to Scopus, placing it in the top 22% of its category. With an impactful Convergence of research from 2015 to 2024, Translational Pediatrics is dedicated to providing an essential platform for high-quality studies that advance pediatric care and foster best practices in child health.

Dementia-International Journal of Social Research and Practice

Exploring innovative social interventions for dementia care.
Publisher: SAGE PUBLICATIONS LTDISSN: 1471-3012Frequency: 8 issues/year

Dementia - International Journal of Social Research and Practice, published by SAGE Publications Ltd, is a premier peer-reviewed journal dedicated to advancing research in the multifaceted arena of dementia care and social interventions. Founded in 2002, this journal has steadily established itself as a key resource for academics and practitioners alike, reflected by its esteemed rankings in the Q1 category across multiple disciplines, including History, Medicine (Miscellaneous), Social Sciences (Miscellaneous), and Sociology and Political Science. With a remarkable Scopus rank of #28 in General Social Sciences and a 90th percentile standing, the journal champions high-impact articles that address the complexities of dementia through interdisciplinary lenses. Although it is not an open-access publication, it provides invaluable insights and cutting-edge research to its subscribers and contributors. This journal is pivotal for anyone engaged in dementia research and practice, offering not only findings from empirical studies but also fostering dialogue on social policies and care practices that enhance the lives of those affected by dementia.

PSYCHOLOGICAL MEDICINE

Pioneering insights in psychiatry and psychology.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0033-2917Frequency: 16 issues/year

PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.

ANNALS OF THE RHEUMATIC DISEASES

Exploring Innovations in Rheumatic Disease Management
Publisher: BMJ PUBLISHING GROUPISSN: 0003-4967Frequency: 12 issues/year

ANNALS OF THE RHEUMATIC DISEASES, published by BMJ Publishing Group, stands as a leading academic journal in the realm of rheumatology and related fields, including biochemistry, immunology, and genetics. With an esteemed impact factor and a consistent ranking in the upper echelons of its category (Q1) as per the latest evaluations, this journal represents the forefront of research and innovation, fostering scientific advancement from 1945 to the present. As the top journal in the Medicine - Rheumatology category and achieving remarkable percentiles in various interdisciplinary categories, it serves as a critical platform for researchers, clinicians, and students dedicated to understanding and addressing rheumatic diseases. Although it does not currently offer open access, its rigorous peer-review process ensures the dissemination of high-quality research findings that are paramount in enhancing clinical practices and advancing scientific discourse. Readers can expect to be challenged and inspired by the breadth of studies and reviews that address the complexities of rheumatology and its intersecting scientific domains.

Current Treatment Options in Rheumatology

Shaping the future of rheumatic care through collaborative research.
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Treatment Options in Rheumatology, published by SPRINGERNATURE, is a pivotal journal focused on advancing the field of rheumatology through the dissemination of cutting-edge research and comprehensive reviews. With an emphasis on current therapeutic strategies, this journal aims to provide healthcare professionals, researchers, and students with up-to-date information on the latest treatment modalities for rheumatic diseases. Although it operates under a subscription model, it offers a platform for sharing significant findings that can influence clinical practice and policy within the field of rheumatology. By promoting insightful discussions and collaborations, Current Treatment Options in Rheumatology plays a crucial role in shaping the future of rheumatic disease management and improving patient outcomes.

Quality in Ageing and Older Adults

Empowering Older Adults with Insightful Solutions
Publisher: EMERALD GROUP PUBLISHING LTDISSN: 1471-7794Frequency: 4 issues/year

Quality in Ageing and Older Adults is an esteemed journal published by Emerald Group Publishing Ltd, dedicated to elucidating the complexities and challenges of aging and the quality of life for older adults. With a focus on critical areas within Care Planning, Community and Home Care, and Gerontology, this journal serves as a vital resource for researchers, healthcare professionals, and students alike. Recognized for its scholarly contributions, it holds a Q2 ranking for Care Planning and Community and Home Care and maintains an impactful presence in Gerontology, further demonstrated by its Scopus rankings. Although the journal does not offer open access, its commitment to advancing knowledge in the field is underscored by its ongoing publication since 2000 and its broad scholarly reach until 2024. By fostering innovative research and practical insights, Quality in Ageing and Older Adults continues to play a crucial role in informing policy, enhancing care practices, and improving outcomes for older individuals.